Endothelin-1/Endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis

Cellular Signalling

Volumn 26, Issue 12, 2014, Pages 2885-2895

  Teoh, Jian peng ^a   Park, Kyoung mi ^a   Wang, Yongchao ^a   Hu, Qiuping ^a   Kim, Sangmi ^a   Wu, Guangyu ^a   Huang, Shuang ^a   Maihle, Nita ^a   Kim, Il man ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Biased G protein coupled receptor signaling; Endothelin axis; Metastatic genes; arrestin

Indexed keywords

BETA ARRESTIN; CYCLIC AMP; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; PROTEIN KINASE C; ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME ACTIVATOR; FORSKOLIN; RETINA S ANTIGEN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

APOPTOSIS; ARTICLE; CALCRL GENE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; ICAM2 GENE; OVARY CANCER; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; WOUND HEALING; BIOLOGICAL MODEL; CELL MOTION; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); OVARY TUMOR; PATHOLOGY; SURVIVAL; TUMOR CELL LINE; VASCULARIZATION;

ADENYLYL CYCLASES; APOPTOSIS; ARRESTINS; CARCINOGENESIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLFORSIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIN-1; ENZYME ACTIVATORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; RECEPTOR, ENDOTHELIN A; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

EID: 84907638077     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.08.024     Document Type: Article

References (71)

1. Schorlemmer A., Matter M.L., Shohet R.V. Trends Cardiovasc. Med. 2008, 18:233-239.
2. Rosano L., Spinella F., Bagnato A. Nat. Rev. Cancer 2013, 13:637-651.
3. Yokoi K., Adachi H., Hirai Y., Enomoto M., Fukami A., Ogata K., et al. Circ. J. 2012, 76:2779-2784.
4. Bagnato A., Spinella F., Rosano L. Can. J. Physiol. Pharmacol. 2008, 86:473-484.
5. Vacca F., Bagnato A., Catt K.J., Tecce R. Cancer Res. 2000, 60:5310-5317.
6. Nelson J.B., Hedican S.P., George D.J., Reddi A.H., Piantadosi S., Eisenberger M.A., et al. Nat. Med. 1995, 1:944-949.
7. Bagnato A., Tecce R., Moretti C., Di Castro V., Spergel D., Catt K.J. Clin. Cancer Res. 1995, 1:1059-1066.
8. Rosano L., Cianfrocca R., Masi S., Spinella F., Di Castro V., Biroccio A., et al. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2806-2811.
9. Rosano L., Di Castro V., Spinella F., Nicotra M.R., Natali P.G., Bagnato A. Mol. Cancer Ther. 2007, 6:2003-2011.
10. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Nature 1990, 348:730-732.
11. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., et al. Nature 1990, 348:732-735.
12. Williams D.L., Jones K.L., Pettibone D.J., Lis E.V., Clineschmidt B.V. Biochem. Biophys. Res. Commun. 1991, 175:556-561.
13. Bagnato A., Salani D., Di Castro V., Wu-Wong J.R., Tecce R., Nicotra M.R., et al. Cancer Res. 1999, 59:720-727.
14. Siegel R., Naishadham D., Jemal A. CA Cancer J. Clin. 2012, 62:10-29.
15. Bhalla A., Haque S., Taylor I., Winslet M., Loizidou M. Eur. J. Clin. Investig. 2009, 39(Suppl. 2):74-77.
16. Rosano L., Spinella F., Di Castro V., Nicotra M.R., Dedhar S., de Herreros A.G., et al. Cancer Res. 2005, 65:11649-11657.
17. Carducci M.A., Jimeno A. Clin. Cancer Res. 2006, 12:6296s-6300s.
18. Grant E.S., Brown T., Roach A., Williams B.C., Habib F.K. J. Clin. Endocrinol. Metab. 1997, 82:508-513.
19. Bagnato A. Curr. Pharm. Des. 2012, 18:2720-2733.
20. Bagnato A., Rosano L. Int. J. Biochem. Cell Biol. 2008, 40:1443-1451.
21. Bagnato A., Rosano L. Curr. Oncol. 2012, 19:36-38.
22. Kim I.M., Tilley D.G., Chen J., Salazar N.C., Whalen E.J., Violin J.D., et al. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14555-14560.
23. Violin J.D., Lefkowitz R.J. Trends Pharmacol. Sci. 2007, 28:416-422.
24. Rajagopal S., Ahn S., Rominger D.H., Gowen-MacDonald W., Lam C.M., Dewire S.M., et al. Mol. Pharmacol. 2011, 80:367-377.
25. Violin J.D., DeWire S.M., Yamashita D., Rominger D.H., Nguyen L., Schiller K., et al. J. Pharmacol. Exp. Ther. 2010, 335:572-579.
26. Kim K.S., Abraham D., Williams B., Violin J.D., Mao L., Rockman H.A. Am. J. Physiol. Heart Circ. Physiol. 2012, 303:H1001-H1010.
27. DeWire S.M., Yamashita D.S., Rominger D.H., Liu G., Cowan C.L., Graczyk T.M., et al. J. Pharmacol. Exp. Ther. 2013, 344:708-717.
28. Boerrigter G., Soergel D.G., Violin J.D., Lark M.W., Burnett J.C. Circ. Heart Fail. 2012, 5:627-634.
29. Spinella F., Rosano L., Di Castro V., Nicotra M.R., Natali P.G., Bagnato A. Clin. Cancer Res. 2004, 10:4670-4679.
30. Buick R.N., Pullano R., Trent J.M. Cancer Res. 1985, 45:3668-3676.
31. Wu M.H., Chen L.M., Hsu H.H., Lin J.A., Lin Y.M., Tsai F.J., et al. Biochim. Biophys. Acta 1830, 2013:3355-3364.
32. Wang H.H., Hsieh H.L., Wu C.Y., Yang C.M. J. Neurochem. 2010, 113:1133-1149.
33. Rosano L., Cianfrocca R., Tocci P., Spinella F., Di Castro V., Spadaro F., et al. Oncogene 2013, 32:5066-5077.
34. Wang Y., Hill K.S., Fields A.P. Mol. Cancer Res. 2013, 11:1624-1635.
35. Nature 2011, 474:609-615.
36. Cerami E., Gao J., Dogrusoz U., Gross B.E., Sumer S.O., Aksoy B.A., et al. Cancer Discov. 2012, 2:401-404.
37. Gao J., Aksoy B.A., Dogrusoz U., Dresdner G., Gross B., Sumer S.O., et al. Sci. Signal. 2013, 6. (pl1).
38. Deacon K., Knox A.J. J. Biol. Chem. 2010, 285:25913-25927.
39. Aramori I., Nakanishi S. J. Biol. Chem. 1992, 267:12468-12474.
40. Oda K., Fujitani Y., Watakabe T., Inui T., Okada T., Urade Y., et al. FEBS Lett. 1992, 299:187-191.
41. De Val S., Chi N.C., Meadows S.M., Minovitsky S., Anderson J.P., Harris I.S., et al. Cell 2008, 135:1053-1064.
42. Kim I.M., Wang Y., Park K.M., Tang Y., Teoh J.P., Vinson J., et al. Circ. Res. 2014, 114:833-844.
43. Jeong M.J., Kim E.J., Cho E.A., Ye S.K., Kang G.H., Juhnn Y.S. FEBS Lett. 2013, 587:1373-1378.
44. Zimmerman N.P., Roy I., Hauser A.D., Wilson J.M., Williams C.L., Dwinell M.B. Mol. Carcinog. 2013, Sep 24. http://dx.doi.org/10.1002/mc.22091. [Epub ahead of print].
45. Ou Y., Zheng X., Gao Y., Shu M., Leng T., Li Y., et al. Urol. Oncol. 2014, 32. (47 e21-8).
46. Follin-Arbelet V., Torgersen M.L., Naderi E.H., Misund K., Sundan A., Blomhoff H.K. Cancer Lett. 2013, 335:323-331.
47. Takahashi A., Kato K., Kuboyama A., Inoue T., Tanaka Y., Kuhara A., et al. Gynecol. Oncol. 2009, 113:270-276.
48. Shaw T.J., Keszthelyi E.J., Tonary A.M., Cada M., Vanderhyden B.C. Exp. Cell Res. 2002, 273:95-106.
49. Frey U.H., Eisenhardt A., Lummen G., Rubben H., Jockel K.H., Schmid K.W., et al. Cancer Epidemiol. Biomarkers Prev. 2005, 14:871-877.
50. Frey U.H., Alakus H., Wohlschlaeger J., Schmitz K.J., Winde G., van Calker H.G., et al. Clin. Cancer Res. 2005, 11:5071-5077.
51. Frey U.H., Lummen G., Jager T., Jockel K.H., Schmid K.W., Rubben H., et al. Clin. Cancer Res. 2006, 12:759-763.
52. Frey U.H., Nuckel H., Sellmann L., Siemer D., Kuppers R., Durig J., et al. Clin. Cancer Res. 2006, 12:5686-5692.
53. O'Hayre M., Vazquez-Prado J., Kufareva I., Stawiski E.W., Handel T.M., Seshagiri S., et al. Nat. Rev. Cancer 2013, 13:412-424.
54. Weinstein L.S., Yu S., Warner D.R., Liu J. Endocr. Rev. 2001, 22:675-705.
55. Sobolesky P.M., Moussa O. Prog. Mol. Biol. Transl. Sci. 2013, 118:395-411.
56. Kaparianos A., Argyropoulou E., Spiropoulos K. Eur. Rev. Med. Pharmacol. Sci. 2012, 16:1781-1794.
57. Shenoy S.K., Han S., Zhao Y.L., Hara M.R., Oliver T., Cao Y., et al. Oncogene 2012, 31:282-292.
58. Singh S., Bora-Singhal N., Kroeger J., Laklai H., Chellappan S.P. PLoS One 2013, 8:e55982.
59. Hagner S., Stahl U., Grimm T., Sturzl M., Lang R.E. J. Clin. Pathol. 2006, 59:1104-1107.
60. Nikitenko L.L., Cross T., Campo L., Turley H., Leek R., Manek S., et al. Clin. Cancer Res. 2006, 12:5648-5658.
61. Benes L., Kappus C., McGregor G.P., Bertalanffy H., Mennel H.D., Hagner S. J. Clin. Pathol. 2004, 57:172-176.
62. Molica S., Dattilo A., Mannella A., Levato D. Leukemia 1996, 10:907-908.
63. Monasky M.M., Taglieri D.M., Henze M., Warren C.M., Utter M.S., Soergel D.G., et al. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H856-H866.
64. Ayoub M.A., Pin J.P. Front. Endocrinol. (Lausanne) 2013, 4:196.
65. Witteveen P.O., van der Mijn K.J., Los M., Kronemeijer R.H., Groenewegen G., Voest E.E. Neoplasia 2010, 12:941-945.
66. Cognetti F., Bagnato A., Colombo N., Savarese A., Scambia G., Sehouli J., et al. Gynecol. Oncol. 2013, 130(1):31-7. Jul.
67. Meacham C.E., Morrison S.J. Nature 2013, 501:328-337.
68. Marte B. Nature 2013, 501:327.
69. Pizon M., Zimon D., Carl S., Pachmann U., Pachmann K., Camara O. Ecancermedicalscience 2013, 7:343.
70. Archetti M. Br. J. Cancer 2013, 109:1056-1062.
71. Holzel M., Bovier A., Tuting T. Nat. Rev. Cancer 2013, 13:365-376.